Related by context. All words. (Click for frequent words.) 69 splice variants 68 experimentally validated 67 ENMD # 67 transcriptome sequencing 66 massively parallel sequencing 66 5 hmC 66 druggable targets 66 siRNA duplexes 66 proteomic analysis 66 CBLC# 66 biomarker identification 66 RT qPCR 66 transcriptional profiling 66 A3 adenosine receptor 66 siRNA knockdown 65 XmAb# 65 ChIP chip 65 transcriptomic 65 splice variant 65 CCX# 65 polyketides 65 synthetic siRNAs 65 pharmacodynamic markers 65 trans splicing 65 multiplexed assays 65 ncRNA 65 BACcel ™ system 65 HTS assay 64 sequenced genomes 64 nanoviricides 64 pyrimidines 64 eTag assays 64 cDNAs 64 malaria parasite genome 64 prognostic markers 64 #S rRNA gene 64 CYT# potent vascular disrupting 64 preclinically 64 immunohistochemical 64 cMET 64 #S rRNA 64 serum biomarkers 64 indibulin 64 ChIP seq 64 Immunohistochemical analysis 64 siRNA therapeutic 64 multiplex assay 64 transgenic mouse models 64 Symadex 64 MET amplification 64 serine protease 64 PSMA ADC 64 QTL mapping 64 Xanafide 64 hybridoma 64 DiLA2 64 lentiviral 64 ESBA# 63 molecular biomarkers 63 Cytolin R 63 sequence homology 63 throughput RNAi 63 primate genomes 63 BioMAP 63 GAP #B# 63 Sphingomab 63 p# antigen 63 ONCONASE R 63 GPx 63 #F FDG PET 63 proteomes 63 E. histolytica 63 chimeric protein 63 antibody arrays 63 #ME# 63 somatic mutations 63 RRM1 63 chromatin immunoprecipitation ChIP 63 favorable pharmacokinetic profile 63 histone deacetylase HDAC 63 DAC Blockers Platform 63 amino acid substitution 63 pharmacodynamic biomarkers 63 phylogenetic analyzes 63 previously uncharacterized 63 IRX 2 63 quantitative PCR 63 CCR9 63 inactivating mutations 63 putative biomarkers 63 Anticalins 62 antiangiogenic activity 62 Cyclin E 62 Anticalins ® 62 Tr DNA 62 BRAF kinase 62 mtDNA mutations 62 Annexin V 62 kidney urologic 62 potent cytotoxic 62 pharmacokinetic characteristics 62 Oral NKTR 62 genomic profiling 62 microRNA expression 62 differential gene expression 62 biochemical assays 62 bioinformatic analysis 62 gene expression microarray 62 anionic backbone 62 K ras mutations 62 p# biomarker 62 splice junctions 62 conserved sequences 62 isotype 62 antisense oligonucleotides 62 BCR ABL mutations 62 MALDI-TOF/TOF 62 SIRT1 activation 62 epistasis 62 peptide conjugated 62 TTR gene 62 sphingolipid 62 AvalonRx R 62 reaction PCR 62 mda 7 62 recombinant antibodies 62 metabolomic profiles 62 antagomirs 62 replicon 62 Nanobody ® 62 proteolytic cleavage 62 kinase profiling 62 NEUGENE 62 M. pneumoniae 62 breast cancer subtypes 62 quantitative gene expression 62 Alfacell proprietary ribonuclease 62 cis regulatory 62 pathophysiological effects 62 cleavable linker 62 genotypic 62 cytosine methylation 62 multiplex PCR 62 vitro cytotoxicity 62 Anticalins R 62 serum antibodies 62 γ secretase 62 BACcel ™ 62 DermaVir 62 cDNA libraries 62 genomic biomarker 62 Bayesian inference 62 endosomal release 62 diagnostic biomarker 62 glycosylated 62 Sanger Sequencing 62 DepoVax ™ 62 antiproliferative effects 62 vitro assay 62 Trofex 61 therapeutic monoclonal antibody 61 metabolite profiling 61 uricase 61 adipogenic 61 OMP #M# 61 adenoviral 61 genetic loci 61 #beta HSD1 61 combinatorial libraries 61 KRAS BRAF 61 solithromycin 61 phosphate S1P 61 N glycan 61 #S rDNA 61 exon skipping 61 methylation markers 61 PEGylated 61 viral genomes 61 ligand binding 61 Vesivirus 61 carcinoembryonic antigen 61 posttranslational modifications 61 florbetaben 61 enzyme immunoassay EIA 61 flow cytometric 61 vivo validation 61 demonstrated antitumor activity 61 HybSelect 61 short hairpin RNAs 61 oral prodrug 61 EML4 ALK 61 etiologic 61 TÎ ² 4 61 small molecule activators 61 orally administered inhibitor 61 SIRT1 activators 61 MALDI MS 61 bacterial genomes 61 haplotyping 61 Angiocept 61 intracellular bacteria 61 JAK2 inhibitors 61 homodimers 61 ANAVEX #-# [001] 61 Western Blotting 61 XL# inhibits 61 PCA3 gene 61 quantitative PCR qPCR 61 Protein Kinase C 61 receptor ligand 61 metabolomic 61 ELISPOT assay 61 S. maltophilia 61 immunomodulation 61 anti angiogenic drugs 61 positional cloning 61 Genotypic 61 genome rearrangements 61 pharmacophore 61 qRT PCR 61 manually curated 61 engineered RAP peptides 61 OncoVEX 61 hypermethylated 61 Nanobody 61 KRAS oncogene 61 5 hydroxymethylcytosine 61 physiologically relevant 61 busulfan 61 Clusterin 61 Anticalin ® 61 Infinium assay 61 CDDO Im 61 CDK inhibitor 61 Nanobodies 61 dAbs 61 Thiarabine 61 IMA# 61 SMaRT ™ 61 coexpression 61 Pichia pastoris 61 Western blotting 61 NADiA 61 RAS RAF MEK 61 dose proportionality 61 MenSCs 61 immunoregulatory 61 hERG 61 humanized antibody 61 microarray gene expression 61 antiangiogenesis 61 indels 61 selective orally bioavailable 61 potent inhibition 61 XOMA 3AB 61 HTRF R 61 transcriptomics 61 Next Generation Sequencing NGS 61 xTAG RVP 61 delafloxacin 61 mass spectrometric 61 ALN TTR 61 modifier genes 61 bisulfite sequencing 61 siRNA sequences 61 monoclonal antibody mAb 61 NITD# 61 RNAi therapeutic targeting 61 vitro dissolution 61 xenograft models 61 microRNA profiling 61 novel VDA molecule 61 TLR9 agonists 61 physicochemical properties 61 protein quantitation 61 gene rearrangements 60 Aplidin R 60 comparative genomic 60 small molecule defensin 60 Immunohistochemical 60 MetaBase TM represents 60 immunohistochemical analysis 60 virulence genes 60 aCGH 60 body louse genome 60 NS#/#A protease 60 isotypes 60 miRview mets 60 constitutively expressed 60 immune stimulatory 60 DepoVax TM 60 Onconase 60 mechanistic insights 60 mammalian organisms 60 evolvability 60 immunotoxin 60 genetic biomarkers 60 non coding RNA 60 T#I [002] 60 alpha fetoprotein AFP 60 prion strains 60 Vaxfectin TM 60 Illumina Solexa 60 delipidation 60 CD1d 60 myelofibrosis polycythemia vera 60 toxicogenomic 60 preclinical efficacy 60 ProMIS TM 60 selective inhibition 60 TIMP 1 60 AEG# 60 chromatin immunoprecipitation 60 phenotypic expression 60 vascular disrupting agents 60 gene expression microarrays 60 directed mutagenesis 60 mRNA transcripts 60 DNA demethylation 60 JAK inhibitors 60 anti amnesic 60 KRAS mutation 60 chromosomal mutations 60 Mass spectrometry 60 missense mutations 60 ImmunoVEX 60 #T# L1 60 cytochrome P# inhibition 60 antisense inhibitors 60 gene expression assays 60 metabolite identification 60 IgG1 60 transcriptional regulation 60 Aspergillus nidulans 60 ETBs 60 Fleximer 60 synthetic peptides 60 exome 60 BHT DNA 60 antiangiogenic agent 60 glycolipids 60 transgenic rats 60 ADME Tox 60 MDRNA proprietary 60 E. faecalis 60 pharmacodynamic profiles 60 Alkaline Phosphatase 60 validated experimentally 60 immunohistochemistry IHC 60 FLT3 60 transgene expression 60 TMPRSS2 ERG fusion 60 tkRNAi 60 viral nucleic acids 60 mass spectrometric analysis 60 proprietary PEGylation 60 UsiRNAs 60 rxRNA 60 BRAF V#E mutation 60 Epstein Barr Virus EBV 60 GelSite polymer 60 NuroPro R 60 MAPK pathway 60 Cardiotoxicity 60 DXL# 60 HuCAL PLATINUM 60 Deinococcus 60 Multimeric 60 Apobec3 60 aneuploid 60 molecular biomarker 60 p# activation 60 histone acetylation 60 CGEN # 60 BiTE 60 metabolomic profiling 60 BACcelr8r TM 60 VeraTag 60 C5aR 60 tubulin inhibitor 60 HER2 overexpression 60 TLR8 60 RGD peptide 60 mutagenesis 60 PCR primers 60 aggregated Abeta 60 genomic biomarkers 60 molecularly targeted 60 effector functions 60 JAK3 60 insertional mutagenesis 60 DiLA2 Platform 60 replicase 60 CCR1 60 PEG SN# 60 Cathepsin B 60 cytolytic 60 proteoglycan 60 MSH2 60 glycosylation profile 60 RNA splicing 60 PI3K inhibitors 60 peptide antigens 60 P#X# 60 Radilex 60 HCV protease 60 K#R [002] 60 mGluR2 NAM 60 Curaxin CBLC# 60 outer membrane proteins 60 Haptoglobin 60 LEX System 60 isatoribine 60 PORxin TM 60 Aptamer 60 Histologic 60 vinca alkaloid 60 CEQ# 60 Psoraxine R 60 predictive biomarkers 60 TP# gene 60 quantitative proteomics 60 Nanobodies ® 60 Meta analyzes 60 allogeneic HCT 60 K RAS 60 Phenotypic 60 cytoprotective 60 CYC# 60 mitochondrial DNA mtDNA 60 vivo electroporation 60 targeted radiotherapeutic 60 genetic modifiers 60 nucleotide substitutions 60 Universal Flu Vaccine 60 heritable variation 60 DNA methylation patterns 60 TriGrid 60 Locked Nucleic Acid LNA 60 antiangiogenic agents 60 protein tyrosine phosphatase 1B 60 Fc gamma receptor 60 ribosomal RNA rRNA 60 nonviral gene therapy 60 Panzem NCD 59 differentially expressed genes 59 mycobacterial 59 transcriptome analysis 59 metastatic neuroendocrine tumors 59 vidofludimus 59 brightfield microscopy 59 cytotoxicity assays 59 Hedgehog inhibitor 59 trophoblast cells 59 meganuclease 59 LT NS# 59 gene amplification 59 protein electrophoresis 59 differentially expressed proteins 59 miRNA biomarkers 59 nCounter Analysis System 59 DLC1 59 serine threonine kinase 59 Cdc7 59 FGFs 59 Immunohistochemistry 59 multigene expression test 59 coding exons 59 R roscovitine 59 non nucleoside 59 aurora kinase 59 multiplex assays 59 SureSelect 59 clinicopathological 59 histopathological 59 clade B 59 lipid particles 59 hyperinsulinemic euglycemic clamp 59 Chemokine Receptor 59 synthetic siRNA 59 Vaxfectin 59 comparative genomic hybridization 59 Oncotype DX colon cancer 59 Curaxin 59 ligand receptor 59 NOD mouse 59 Rigel R# 59 fibrotic disease 59 orthologous 59 protein ligand 59 ATL# [002] 59 Phase Ib study 59 tiny roundworm 59 CXCR7 59 polyploid 59 alpha7 59 TET2 59 ActA 59 recombinant antibody 59 shRNAs 59 carcinoids 59 potent inhibitors 59 Telatinib 59 PML RARA 59 Cathepsin S 59 LRP5 59 pyrimidine 59 promoter methylation 59 picomolar 59 NPC 1C 59 RNA silencing 59 gene locus 59 immunohistochemical staining 59 flavopiridol 59 siRNAs targeting 59 secretory pathway 59 Guanilib 59 lymphoid tumors 59 site directed mutagenesis 59 PARP inhibition 59 proteomic analyzes 59 potent suppressor 59 microRNA miRNA 59 anti fibrotic 59 bispecific antibody 59 phage display 59 phenotyping 59 genomic microarray 59 enzymatically active 59 protein microarrays 59 FUS1 59 Bafetinib 59 Corgentin 59 vitro transcription 59 delta opioid receptor 59 vivo potency 59 HDAC inhibition 59 oral picoplatin 59 MassARRAY ® 59 L. pneumophila 59 sDNA 59 monoclonals 59 FluChip 59 nucleosides 59 kinome 59 quasispecies 59 KinomeScan 59 SELDI TOF MS 59 mutational analysis 59 neuronal nicotinic receptor NNR 59 cell lysate 59 Pepducin 59 Zysolin TM 59 mertansine 59 Estrogen Receptor 59 ribosomal DNA 59 HAAH 59 TLR agonists 59 PI3K Akt 59 potent antitumor activity 59 PIK3CA 59 tumorigenicity 59 Mass Spectrometry MS 59 glutamic acid decarboxylase 59 monogenic 59 HuMax CD#b 59 lysate 59 antisense compounds 59 de novo sequencing 59 ChIP Seq 59 PEGylated interferon 59 LHRH antagonists 59 radiolabeled 59 HER2 HER3 59 proprietary PharmacoSurgery ™ 59 NKT cell 59 SERMs 59 microwell plate 59 Nedd4 59 histone modifications 59 amplicon 59 PET tracers 59 theranostic 59 lipidoid 59 introgression 59 Geniom RT Analyzer 59 paralogs 59 immunoblotting 59 MVA BN R 59 noncoding RNA 59 immunoblot 59 TRIOLEX HE# 59 serum antibody 59 Histone deacetylase 59 Corus CAD 59 genotyping arrays 59 underlying molecular mechanisms 59 Deforolimus 59 radiolabeling 59 Leydig cells 59 pharmacodynamic properties 59 histopathologic 59 5 HT2A serotonin 59 EZN 59 siRNA mediated 59 TNFalpha 59 Flow cytometry 59 OTCBB PWRM.OB 59 haematologic 59 Her2/neu 59 next generation URAT1 59 CCR5 antagonist 59 liposomal formulation 59 novel peptide 59 Vaxfectin R adjuvant 59 fungal genomes 59 Monoclonal 59 MAbs targeting 59 tumor necrosis 59 tyrosine phosphorylation 59 phenotypic traits 59 RayBiotech 59 pleiotropy 59 QPCR 59 selective kinase inhibitors 59 HepaLife PICM 59 kinase inhibition 59 homologies 59 ganetespib 59 amyloid deposition 59 C#T [002] 59 microRNA biomarkers 59 miRNA molecules 59 Gastrointestinal Stromal Tumors 59 cDNA synthesis 59 Mutational 59 immatics 59 GLP toxicology studies 59 VeraCode 59 mAbs 59 tumor xenograft models 59 Trofile assay 59 vivo pharmacology 59 relapsed MM 59 CpG island 59 cyclin dependent kinases CDKs 59 XmAb ™ 59 mediated inhibition 59 PhG alpha 1 59 p# MAPK 59 epithelial tumors 59 LSI #P 59 TPI ASM8 59 affinity purification 59 transdifferentiation 59 ABL1 59 thalidomide Thalomid 58 neuropathologic 58 ultrastructural 58 IGFBP2 58 VEGFR1 58 biased ligand 58 GMX# 58 sarcosine 58 immunological responses 58 neurite outgrowth 58 enzymatic pathways 58 siRNA conjugates 58 THR beta agonist 58 Traficet EN 58 butyrylcholinesterase 58 embryoid bodies 58 CYP#A# CYP#D# 58 diagnostic biomarkers 58 Illumina GoldenGate 58 filoviruses 58 CXCR4 receptor 58 RNAi mediated 58 chromosome aberrations 58 shRNA libraries 58 Gag polymorphisms 58 STEEN Solution ™ 58 predictive biomarker 58 candidates Azedra TM 58 M1 muscarinic 58 PI3K/Akt pathway inhibitor 58 BACcel 58 organophosphorus compounds 58 CSHL scientists 58 Affilin ® 58 QRT PCR 58 HIF PH inhibitors 58 Drosophila genome 58 pre malignant lesions 58 microcephalin 58 transfection reagent 58 PROCHYMAL 58 pharmacokinetic PK study 58 genomewide 58 functional annotation 58 liposome formulations 58 predictive toxicology 58 scintigraphic 58 acetylcholinesterase AChE 58 HCV replicon 58 KIAA# 58 enzyme catalysis 58 transgenesis 58 stem cell pluripotency 58 EGS# 58 chromosomal DNA 58 Syllego system 58 molecular assays 58 morphologic 58 TAKSTA 58 homologous genes 58 deacetylase inhibitors 58 antiapoptotic 58 nonviral 58 hPTH #-# 58 endogenous ligands 58 Trofile TM 58 gDNA 58 benign neoplasms 58 UCOE 58 prognostic indicators 58 neutralizing antibody responses 58 MLL2 58 HER2 expression 58 NEUGENE antisense 58 CRLX# 58 phosphorylated proteins 58 anticoagulant reversing agent 58 preclinical pharmacokinetic 58 vitro experiments 58 quantitative trait loci 58 lipid nanoparticles 58 TPMT 58 antibody fragment 58 Sphingomab TM 58 Tem PCR 58 genomic proteomic 58 Sanger sequencing 58 virus AAV 58 cathepsins 58 polymerase inhibitors 58 FKBP# 58 CyPath ® assay 58 CHO K1 58 TRO# 58 NSCLC tumors 58 heterologous expression 58 vitro ADME 58 influenza VLP vaccine 58 gamete formation 58 xCELLigence 58 Peptidomics 58 MEK inhibitors 58 OnDose TM 58 gene loci 58 eukaryotic genomes 58 tRNA synthetases 58 tests miRview TM 58 monomeric 58 radiolabeled TM# 58 methylated DNA 58 mesenchymal stem cells MSCs 58 P. falciparum parasites 58 posttranslational modification 58 subunit vaccine 58 rxRNA compounds 58 immune modulating 58 chemosensitivity 58 metazoans 58 protein ligand interactions 58 DNA methyltransferases 58 antisense inhibition 58 allelic variation 58 chemokine receptor 58 pharmacodynamic endpoints 58 small molecule activator 58 AttoSense 58 TBC# 58 exome capture 58 beta lactams 58 Arabidopsis genome 58 dbSNP 58 tumor biopsies 58 transfection efficiency 58 heterologous 58 EDEMA3 trial 58 SILAC 58 Eg5 58 Lymph node 58 bioconjugation 58 Alu elements 58 Annexin A5 58 bioinformatic 58 Valortim ® 58 MAb 58 nucleotide variations 58 muscarinic 58 HemoGenix 58 EUS FNA 58 hypoxia selective 58 metaplasia 58 GNAQ 58 comparative genomic analysis 58 hpSCs 58 tumor antigen 58 CellPort Technologies 58 haplotype map 58 synDNA TM 58 annexin V 58 metabonomics 58 PCR RFLP 58 nucleic acid molecules 58 CeaProve 58 Xencor XmAb 58 pathogen interactions 58 EKC Cide 58 Immunohistochemical staining 58 Tyrima 58 epistatic 58 Cyclosert 58 IMPDH 58 plasma pharmacokinetics 58 biostatistical analysis 58 Interferon alpha 58 Anavex #-# 58 chromosomal rearrangement 58 N. gonorrhoeae 58 secretory phospholipase A2 sPLA2 58 physicochemical 58 CG# [003] 58 transcriptomes 58 somatostatin receptor 58 immunodominant 58 TransVax ™ 58 tiapamil 58 IgG1 antibody 58 patented NanoStat TM 58 RAV# 58 fusion enhancers 58 Darinaparsin 58 smooth muscle contractility 58 Tyrosine Kinase Inhibitor 58 miRNA expression 58 BMP2 58 NS5A 58 OncoVEX GM CSF 58 nucleic acid isolation 58 viral proteins 58 Epigenomics proprietary 58 Bayesian statistical 58 eIF4E 58 biomarker validation 58 Alocrest 58 elacytarabine 58 Mycoplasma genitalium 58 CD# ligand 58 tumor specific antigen 58 single molecule sequencing 58 buccal delivery 58 MKC# MKC# PP 58 orally bioavailable mimics 58 tigecycline 58 genotyping gene expression 58 Janus kinase 58 Antigenics QS 58 Human cl 58 NS4B 58 leiomyoma 58 anti CD# antibodies 58 Morpholino 58 serine threonine 58 anti CD3 58 drugable targets 58 EphA2 58 endophenotypes 58 plasma lipoprotein 58 DiLA 2 58 granzyme 58 potent antiproliferative 58 novel therapeutic antibodies 58 DermaVir Patch 58 Replikins 58 differentiate squamous 58 rifamycins 58 FCGR3A 58 MGN# 58 mechanistic studies 58 ALK inhibitors 58 S. pombe 58 bioinformatic analyzes 58 alpha folate receptor 58 Solazed TM 58 structural rearrangements 58 Vaxfectin R 58 diagnostic prognostic 58 HER1 58 mutated K ras 58 NS5b 58 Oncogenic 58 intranasal delivery 58 CD# expressing 58 extracellular domains 58 previously undescribed 58 immunochemical 58 Archexin 58 pleiotropic 58 ON #.Na 58 ERK1 2 58 Fragment Library 58 hESC derived cardiomyocytes 58 Schisandrin B 58 GeneSifter 58 AtuRNAi 58 racemic baclofen 58 MGd 58 telomerase inhibitor 58 Corynebacterium 58 molecular abnormalities 58 Microarray analysis 58 depsipeptide 58 unnatural amino acids 58 MTT assay 58 Safinamide 58 CRAC channel 58 Carfilzomib 58 neuropsychiatric diseases 58 Upregulation 58 Phylogenetic analyzes 58 Mucosal 58 nucleotide sequence 58 HLA alleles 58 Trichophyton rubrum 58 ENPP1 58 radezolid 58 Transcriptome 58 PI3K inhibitor 58 Oncotype 58 FGFR3 58 norepinephrine reuptake inhibition 58 kallikrein 58 immunostaining 58 fosbretabulin 58 sd rxRNA 58 antibiofilm 58 protein tyrosine phosphatase 58 cationic lipids 58 biomarker assays 58 dosimetric 58 4E BP1 58 GelSite R polymer 58 pharmacokinetic PK 58 DCVax R 58 lentiviral vectors 58 OpenArray platform 58 protein biosynthesis 58 prokaryotic 58 miRNA sequences 58 cDNA microarray 58 Fas ligand 58 HyACT 58 Nucleic acids 58 Tumor Response 58 dephosphorylation 58 iTRAQ 58 LRAT 58 peptide ligands 58 CDK4 57 LPA1 receptor 57 mRNA sequences 57 pharmacokinetic interactions 57 Bacillus subtilis 57 peptidomimetic 57 Virulizin ® 57 co receptor tropism 57 antiproliferative activity 57 PITX2 57 QuadraSphere 57 Azedra ™ 57 PNP inhibitor 57 NPM1 57 EGFR TKIs 57 percutaneous biopsy 57 humanized monoclonal antibodies 57 CLORETAZINE TM VNP#M 57 gene inactivation 57 plasma proteome 57 C. neoformans 57 proto oncogene 57 H#K#me# 57 NuroPro PD 57 situ hybridization 57 HCT# 57 PORxin 57 troponin assay